Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aclarion, Inc. (ACON)
NASDAQ:ACON
Aclarion, Inc. (ACON) Stock Price & Analysis
63 Followers
ACON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.27 - $11.50
Previous Close$0.3
Volume111.39K
Average Volume (3M)2.48M
Market Cap
$2.47M
Enterprise Value$1.01M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$670.15K
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Aug 25, 2023EPS Estimate
-$1.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.67
Shares Outstanding8,203,500
10 Day Avg. Volume199,683
30 Day Avg. Volume2,479,071
Standard Deviation0.27
R-Squared0.00788
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)-1.16
Price to Sales (P/S)30.71
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue14.07
Enterprise Value/Gross Profit-3.11K
Enterprise Value/Ebitda-0.19
Forecast
1Y Price Target
$1.50Price Target Upside409.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Aclarion, Inc. News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceACON's GAAP loss per share was narrower than expected, indicating better cost management.
Market ExpansionThe introduction of Nociscan 2.6 expands the number of MRI systems compatible with the technology, increasing accessibility to medical facilities.
Product EfficacyThe company's Nociscan solution is included in Norway's LIFEHAB Trial, potentially validating its efficacy for diagnosing lower back pain.
Bears Say
Commercial PerformanceThe pace of commercialization has not met initial expectations, leading to lowered revenue estimates.
Earnings ReportACON reported quarter results with revenue slightly below estimate.
Stock StructureACON's stock underwent a 1-for-16 reverse stock split, reflecting a significant reduction in the price per share from previous levels.
---
Ownership Overview
3.67%
Insiders
0.05% Mutual Funds
1.40% Other Institutional Investors
94.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ACON FAQ
What was Aclarion, Inc.’s price range in the past 12 months?
Aclarion, Inc. lowest stock price was $0.27 and its highest was $11.50 in the past 12 months.
What is Aclarion, Inc.’s market cap?
Currently, no data Available
When is Aclarion, Inc.’s upcoming earnings report date?
Aclarion, Inc.’s upcoming earnings report date is Aug 25, 2023 which is 327 days ago.
How were Aclarion, Inc.’s earnings last quarter?
Currently, no data Available
Is Aclarion, Inc. overvalued?
According to Wall Street analysts Aclarion, Inc.’s price is currently Undervalued.
Does Aclarion, Inc. pay dividends?
Aclarion, Inc. does not currently pay dividends.
What is Aclarion, Inc.’s EPS estimate?
Aclarion, Inc.’s EPS estimate is -$1.44.
How many shares outstanding does Aclarion, Inc. have?
Aclarion, Inc. has 8,210,671 shares outstanding.
What happened to Aclarion, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aclarion, Inc.?
Currently, no hedge funds are holding shares in ACON
---
Aclarion, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.06%
12-Months-Change
Fundamentals
Return on Equity
-337.53%
Trailing 12-Months
Asset Growth
100.24%
Trailing 12-Months
Company Description
Aclarion, Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine.
---
ACON Stock 12 Month Forecast
Average Price Target
$1.50
▲(409.51% Upside)
Technical Analysis
Best Analysts Covering ACON
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-46.05%
reiterated a buy rating 2 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -46.05% per trade.
---